Revaesal Sustained Release Tablets 150 mg (Rabeprazole)

Adult dose

Adults should take 1 tablet twice a day, once in the morning and once in the evening. The tablet should be swallowed whole and should not be divided or chewed.

This medication should not be used in patients with a history of hypersensitivity to any component of this medication. Gastrointestinal discomfort may occur during the use of this medication, and symptoms such as nausea, dyspepsia, and abdominal pain may arise. Rarely, allergic reactions such as skin rash or itching may occur, so if such symptoms appear, the medication should be discontinued immediately and a doctor should be consulted. This medication should be used cautiously in pregnant women or those who may become pregnant, and should only be administered if the benefits of the medication outweigh the risks. Breastfeeding women should avoid this medication as it may be transferred through breast milk. Safety in children and adolescents has not been sufficiently established, so caution is required when using this medication in these populations. Older adults should be particularly cautious of adverse reactions such as gastrointestinal symptoms due to decreased physiological function.

Serious side effects

• Hives
• severe swelling (edema)
• shock
• symptoms resembling anaphylaxis
• thrombocytopenia
• leukopenia
• liver dysfunction
• jaundice
• severe allergic reactions
• severe skin adverse reactions

Mild side effects

• Nausea
• abdominal distension
• epigastric pain
• constipation
• diarrhea
• dyspepsia
• nasopharyngitis
• epididymitis
• pharyngotonsillitis
• muscle pain

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's efficacy.

Appearance

White oblong sustained release tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle